Early research (Phase 1)Study completedNCT00049296What this trial is testingThalidomide and Docetaxel in Treating Patients With Advanced CancerWho this might be right forCancer Case Comprehensive Cancer Center 26
Testing effectiveness (Phase 2)Study completedNCT02038946What this trial is testingStudy of Nivolumab in Subjects With Relapsed or Refractory Follicular Lymphoma (FL) (CheckMate 140)Who this might be right forLymphoma Bristol-Myers Squibb 116
Early research (Phase 1)Study completedNCT00005580What this trial is testingBryostatin + Fludarabine in Treating Patients With Chronic Lymphocytic Leukemia or Relapsed Indolent Non-Hodgkin's LymphomaWho this might be right forLeukemiaLymphoma Virginia Commonwealth University 54
Testing effectiveness (Phase 2)Study completedNCT00438880What this trial is testingAgatolimod Sodium, Rituximab, and Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Recurrent or Refractory Non-Hodgkin LymphomaWho this might be right forAdult Non-Hodgkin LymphomaExtranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid TissueNodal Marginal Zone Lymphoma+9 more Mayo Clinic 38
Testing effectiveness (Phase 2)Study completedNCT00096096What this trial is testingTacrolimus and Mycophenolate Mofetil in Preventing Acute Graft-Versus-Host Disease in Patients With Advanced Hematologic Cancer Who Are Undergoing Donor Stem Cell TransplantationWho this might be right forChronic Myeloproliferative DisordersGraft Versus Host DiseaseLeukemia+4 more Fred Hutchinson Cancer Center
Testing effectiveness (Phase 2)Study completedNCT00489203What this trial is testingBeclomethasone Dipropionate in Preventing Acute Graft-Versus-Host Disease in Patients Undergoing a Donor Stem Cell Transplant for Hematologic CancerWho this might be right forHematopoietic/Lymphoid CancerAccelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in Remission+133 more Fred Hutchinson Cancer Center 140
Testing effectiveness (Phase 2)Active Not RecruitingNCT03147885What this trial is testingSelinexor Plus Combination Chemotherapy in Treating Patients With Advanced B Cell Non-Hodgkin LymphomaWho this might be right forDiffuse Large B-Cell LymphomaRecurrent B-Cell Non-Hodgkin LymphomaRecurrent Extranodal Marginal Zone Lymphoma+12 more Barbara Ann Karmanos Cancer Institute 43
Early research (Phase 1)Study completedNCT00019838What this trial is testingUCN-01 and Fludarabine in Treating Patients With Recurrent or Refractory Lymphoma or LeukemiaWho this might be right forLeukemiaLymphoma National Cancer Institute (NCI)
Not applicableNot Yet RecruitingNCT07476378What this trial is testingEvaluate MTM-H-001 Injection in Adult Participants With Relapsed or Refractory B-cell MalignanciesWho this might be right forLymphoma, Large B-Cell, Diffuse (DLBCL)Lymphoma, FollicularLymphoma, Mantle-Cell+3 more Cancer Institute and Hospital, Chinese Academy of Medical Sciences 69
Early research (Phase 1)Study completedNCT00003451What this trial is testingInterleukin-12 Followed by Interferon Alfa in Treating Patients With Advanced CancerWho this might be right forChronic Myeloproliferative DisordersLeukemiaLymphoma+4 more National Cancer Institute (NCI) 40
Large-scale testing (Phase 3)Study completedNCT03570892What this trial is testingTisagenlecleucel in Adult Patients With Aggressive B-cell Non-Hodgkin LymphomaWho this might be right forNon-Hodgkin Lymphoma Novartis Pharmaceuticals 330
Testing effectiveness (Phase 2)Ended earlyNCT01116232What this trial is testingSirolimus, Tacrolimus, Thymoglobulin and Rituximab as Graft-versus-Host-Disease Prophylaxis in Patients Undergoing Haploidentical and HLA Partially Matched Donor Hematopoietic Cell TransplantationWho this might be right forChronic Myeloproliferative DisordersGraft Versus Host DiseaseLeukemia+5 more Barbara Ann Karmanos Cancer Institute 4
Very early researchUnknownNCT04184414What this trial is testingThe Clinical Application of Chimeric Antigen Receptor T Cells in the Treatment of CD19 Positive Recurrent Refractory B Cell-derived Hematological MalignanciesWho this might be right forB Acute Lymphoblastic LeukemiaMantle Cell LymphomaFollicular Lymphoma PersonGen BioTherapeutics (Suzhou) Co., Ltd. 10
Testing effectiveness (Phase 2)Study completedNCT03276468What this trial is testingEvaluation of Atezolizumab-Venetoclax-Obinutuzumab Combination in Relapse/Refractory LymphomasWho this might be right forFollicular LymphomaDiffuse Large B Cell LymphomaMarginal Zone Lymphoma+1 more The Lymphoma Academic Research Organisation 136
Early research (Phase 1)Active Not RecruitingNCT04049513What this trial is testingENABLE-1 (Engaging Toll-like Receptor Signalling for B-cell Lymphoma Chimeric Antigen Receptor Therapy)Who this might be right forLymphomas Non-Hodgkin's B-CellDiffuse Large B-cell Lymphoma (DLBCL)Primary Mediastinal B-cell Lymphoma (PMBCL)+3 more Malaghan Institute of Medical Research 30
Testing effectiveness (Phase 2)Study completedNCT03010358What this trial is testingEntospletinib and Obinutuzumab in Treating Patients With Relapsed Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, or Non-Hodgkin LymphomaWho this might be right forAnemiaB-Cell Prolymphocytic LeukemiaGrade 1 Follicular Lymphoma+11 more Alexey Danilov, MD 24
Testing effectiveness (Phase 2)Ended earlyNCT01799889What this trial is testingStudy to Evaluate Efficacy, Safety, Tolerability, and Pharmacodynamics of Entospletinib in Adults With Relapsed or Refractory Hematologic MalignanciesWho this might be right forChronic Lymphocytic LeukemiaMantle Cell LymphomaDiffuse Large B-cell Lymphoma+2 more Gilead Sciences 326
Not applicableEnded earlyNCT00904514What this trial is testingStudy of Previously Collected and Stored Tissue Samples From Patients Previously Enrolled in a Completed National Cancer Institute Clinical TrialWho this might be right forCancer National Institutes of Health Clinical Center (CC) 241
Testing effectiveness (Phase 2)Study completedNCT05008055What this trial is testingStudy of Capivasertib in Relapsed or Refractory B-cell Non-Hodgkin LymphomaWho this might be right forRelapsed or Refractory B-cell Non-Hodgkin Lymphoma AstraZeneca 30
Early research (Phase 1)Study completedNCT00040950What this trial is testingBiological Therapy Plus Monoclonal Antibody Therapy in Treating Patients With Relapsed or Refractory Non-Hodgkin's LymphomaWho this might be right forLymphoma Jonsson Comprehensive Cancer Center